Table 2 Characteristics of bleeding and nonbleeding patients
Characteristic | Bleeding | No bleeding | P-value |
|---|---|---|---|
Total number (n=64) | 39/64 (60.9%) | 25/64 (39.1%) | NA |
Median body weight, kg (range) | 74 (48–108) | 69.5 (44–114) | 0.49 |
Male, % | 64.1% | 64% | 0.99 |
Antiplatelet or anticoagulant Tx | 13/39 (33.3%) | 5/25 (20%) | 0.25 |
Antiplatelet therapy | 8/39 (20.5%) | 4/25 (16%) | 0.65 |
Oral AC/heparin | 6/39 (15.4%) | 1/25 (4%) | 0.15 |
Median platelet count, G/l (range) | 116.5 (38–303) | 137 (51–328) | 0.0012 |
Median hemoglobin, mg/dl (range) | 12.6 (9.2–16.7) | 12.1 (8.3–17.1) | 0.16 |
Median WBC, G/l (range) | 21.8 (4.3–347.8) | 16.0 (2.2–397) | 0.41 |
